Shigeaki Kato, the former University of Tokyo endocrinology researcher who resigned in 2012 and has retracted at least ten papers, by our count, has five more retractions.
Here are the papers, all in the Journal of Biological Chemistry (JBC): Continue reading Five more retractions appear for Shigeaki Kato
A study published in Glia is being retracted following a university investigation that found “incorrect and, therefore, misleading” results in a number of figures.
Here’s the notice for “Jagged1 regulates the activation of astrocytes via modulation of NFκB and JAK/STAT/SOCS pathways” by Eleonora Morga, Laila Mouad-Amazzal, Paul Felten, Tony Heurtaux, Mike Moro, Alessandro Michelucci, Sebastien Gabel, Luc Grandbarbe, and Paul Heuschling: Continue reading University of Luxembourg investigation leads to neuroscience retraction
A former postdoc at the National Institutes of Health (NIH) committed misconduct in a study of hepatitis by falsely claiming that data from a single trial subject were actually from more than a dozen different people, the Office of Research Integrity (ORI) has found.
The investigation was prompted by allegations made by readers of the paper. Baoyan Xu made what the ORI called “a limited admission” that “some better looking strips were repeatedly used as representatives for several times [sic].”
According to a report of the ORI’s findings to be published in the Federal Register tomorrow, the paper, “Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing, published earlier this year in the Proceedings of the National Academy of Sciences (PNAS): Continue reading Former NIH scientist falsified images in hepatitis study: ORI
R. Wayne Alexander, a cardiology researcher at Emory whose lab has retracted four papers following university investigations, has notched retractions five and six.
Here’s the notice from Circulation Research: Continue reading Emory cardiology researcher up to six retractions
Pharmacology Biochemistry and Behavior had a curious retraction notice in September that we’re just now getting around to, but we think you’ll find it to have been worth the wait.
The article, “Interaction of Somatostatin Receptor-2 and Neuropeptide Y Receptor-1 in mice dorsal root ganglion neurons on the Pinch-Nerve injury model,” came from a group in Harbin, China, and Frieburg, Germany, and was published in April 2013.
According to the notice: Continue reading “Not suitable in this context” means retraction in pharmacology journal
Two researchers in Denmark are guilty of scientific dishonesty, the Danish Committees on Scientific Dishonesty (DCSD, Danish acronym UVVU) has concluded.
In July, the DCSD said in a draft report that Bente Klarlund Pedersen had acted in a “scientifically dishonest” and “grossly negligent” manner. She — and many of her defenders — responded by saying that while she had made mistakes, she had not committed misconduct. Here’s a key quote from a letter her attorney wrote to the committee: Continue reading Danish commitee finds Klarlund Pedersen, Penkowa guilty of scientific dishonesty
A group at the University of Texas Southwestern that retracted five papers last year has retracted one more, and has had a paper subjected to an Expression of Concern at the request of the school’s dean.
Here’s the retraction notice for “DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers,” originally published in the British Journal of Cancer and cited 51 times, according to Thomson Scientific’s Web of Knowledge:
Continue reading Cancer biology group notches sixth retraction, and earns an Expression of Concern
The Journal of Neuroscience has retracted a 2011 paper by a group of UCLA researchers after the institution concluded that a post-doc at the institution had falsified data.
The article, “Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging,” came from the lab of Cui-Wei “Tracy” Xie, a behavioral scientist. It has been cited 42 times, according to Thomson Scientific’s Web of Knowledge.
Here’s the retraction notice: Continue reading UCLA probe ends in retraction for neuroscience post-doc
The authors of a 2008 study purporting to explain how the herbicide atrazine acts on cancer cells have asked the journal that published it to retract it for “inadvertent errors,” Retraction Watch has learned.
The notice for “G-Protein-Coupled Receptor 30 and Estrogen Receptor-a are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells,” published in Environmental Health Perspectives, will read: Continue reading Herbicide-ovarian cancer study to be retracted
Shikeagi Kato, an endocrinology researcher who resigned from the University of Tokyo in March 2012 amid an investigation that concluded 43 of his papers should be retracted, has retracted five more papers.
The newest is in this week’s Nature, for “GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis,” a paper first published in 2009. Here’s the notice: Continue reading Shigeaki Kato notches five more retractions, including one in Nature